Clinical Trials Directory

Trials / Completed

CompletedNCT03580499

Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy

A Pilot Study of the Effects of Vitamin B6 on Hot Flash Symptoms in Prostate Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Academic / Other
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

This pilot phase II trial studies how well vitamin B6 works in reducing hot flashes in participants with prostate cancer undergoing antiandrogen therapy. A nutritional supplement such as vitamin B6 may help improve hot flashes caused by antiandrogen therapy in participants with prostate cancer.

Detailed description

PRIMARY OBJECTIVES: I. To evaluate the effect of Vitamin B6 in improves the frequency or severity of hot flashes in prostate cancer patients receiving antiandrogen therapy (androgen deprivation therapy \[ADT\]). OUTLINE: Participants receive vitamin B6 orally (PO) daily for 12 weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin B6Given PO
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2018-09-13
Primary completion
2024-06-30
Completion
2024-07-01
First posted
2018-07-09
Last updated
2025-10-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03580499. Inclusion in this directory is not an endorsement.